Acupuncture on Cardiac and Autonomic Function in Human Heart Failure
1 other identifier
interventional
14
1 country
1
Brief Summary
Acupuncture treatment may improve the cardiac function and the quality of life in heart failure patients. These effects may be related to the inhibition of sympathetic activity and/or increased vagal function. The suppression of inflammatory reaction with acupuncture treatment may also be associated with these outcomes. Specific aims include:
- 1.To evaluate the effect of acupuncture treatment on human cardiac sympathetic/vagal activity
- 2.To evaluate the effect of acupuncture treatment on cardiac function and functional capacity
- 3.To evaluate the general health score of the quality-of-life with acupuncture treatment
- 4.To explore the mechanism of acupuncture treatment on inflammation and nitrative stress in heart failure patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2013
CompletedFirst Posted
Study publicly available on registry
March 5, 2013
CompletedStudy Start
First participant enrolled
May 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2015
CompletedResults Posted
Study results publicly available
March 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedNovember 4, 2025
October 1, 2025
1.7 years
March 4, 2013
June 5, 2018
October 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Cardiac Function: LVEF
Left ventricular ejection fraction (LVEF) percentage was measured at baseline, after 5 weeks of no treatment and just prior to acupuncture treatment, and after 5 weeks of acupuncture treatments.
Baseline, Week 7, Week 13
Change in 6-Minute Walk Distance
Baseline, Week 7, Week 13
Secondary Outcomes (1)
Change in Quality of Life (QOL)
Baseline, Week 7, Week 13
Study Arms (2)
Acupuncture
EXPERIMENTAL10 standardized verum acupuncture (VA) sessions twice a week, over 5 weeks. The 5 weeks of acupuncture were scheduled after the period of no acupuncture for each subject.
No Acupuncture
PLACEBO COMPARATORNo acupuncture treatment or other study intervention over 5 weeks. All subjects had a 5 week period of "no acupuncture" prior to the 5 weeks of acupuncture sessions.
Interventions
No intervention during this period. This was a control period. Each subject acted as their own control.
Eligibility Criteria
You may qualify if:
- Age ≥ 21 years
- Congestive Heart Failure (CHF), New York Heart Association (NYHA) class II-III, Left Ventricular Eject Fraction (LVEF) ≤40%
- All patients will have sinus rhythm and compensate with individually optimized standard heart failure medications. Routine medications will be continued during the study period
- Able and willing to give informed consent or comply with study procedures.
You may not qualify if:
- Acupuncture treatment within 3 months before the beginning of the study
- Presents with cutaneous eczema at potential acupoints
- Have a history of major bleeding or increased propensity of excessive bleeding due to platelet dysfunction
- Currently taking anti-coagulants (e.g. warfarin)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Related Publications (4)
Middlekauff HR, Hui K, Yu JL, Hamilton MA, Fonarow GC, Moriguchi J, Maclellan WR, Hage A. Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients. J Card Fail. 2002 Dec;8(6):399-406. doi: 10.1054/jcaf.2002.129656.
PMID: 12528093BACKGROUNDKurono Y, Minagawa M, Ishigami T, Yamada A, Kakamu T, Hayano J. Acupuncture to Danzhong but not to Zhongting increases the cardiac vagal component of heart rate variability. Auton Neurosci. 2011 Apr 26;161(1-2):116-20. doi: 10.1016/j.autneu.2010.12.003. Epub 2011 Jan 7.
PMID: 21216208BACKGROUNDDeng YJ, Liang WX, Cheng SY. [Influence of acupoint-catgut-implantation on blood pressure and cardiac function in chronic congestive heart failure rats]. Zhen Ci Yan Jiu. 2011 Feb;36(1):40-5. Chinese.
PMID: 21585058BACKGROUNDKristen AV, Schuhmacher B, Strych K, Lossnitzer D, Friederich HC, Hilbel T, Haass M, Katus HA, Schneider A, Streitberger KM, Backs J. Acupuncture improves exercise tolerance of patients with heart failure: a placebo-controlled pilot study. Heart. 2010 Sep;96(17):1396-400. doi: 10.1136/hrt.2009.187930. Epub 2010 Jun 15.
PMID: 20554511BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
These results should be interpreted with caution. With only 10 subjects, the study may be under-powered to detect a significant difference.
Results Point of Contact
- Title
- Dr. W.H. Wilson Tang, MD
- Organization
- Cleveland Clinic Foundation
Study Officials
- PRINCIPAL INVESTIGATOR
W.H. Wilson Tang, MD
The Cleveland Clinic
- PRINCIPAL INVESTIGATOR
Yanming Huang, MD PhD
The Cleveland Clinic
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Cellular and Molecular Medicine and Cardiovascular Medicine
Study Record Dates
First Submitted
March 4, 2013
First Posted
March 5, 2013
Study Start
May 13, 2013
Primary Completion
January 9, 2015
Study Completion
December 1, 2021
Last Updated
November 4, 2025
Results First Posted
March 29, 2019
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual patient data available.